A follow-up of the ALFoNS randomised trial found that early growth differences between infants fed low-protein formulas, standard formula or breast milk did not persist at later childhood assessments. The research was published in Nutrients, with some authors employed by Arla, which supplied the whey ingredients used in the modified formulas.
This is infant nutrition research with no direct bearing on feed grain, oilseed or livestock commodity supply, demand or prices. The dairy ingredient link to Arla is commercial context rather than a market driver.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.